Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.40% Nasdaq Up0.97%

Sarepta Therapeutics, Inc. (SRPT)

38.79 4.81(14.16%) Apr 22, 4:00PM EDT
Get the big picture on all your investments.
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.2
Mean Recommendation (last week):2.7

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:41.77
Median Target:46.00
High Target:63.00
Low Target:10.00
No. of Brokers:13

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jan 21, 2014NeedhamUpgradeHoldBuy
Nov 26, 2013WBB SecuritiesUpgradeSellSpeculative Buy
Nov 13, 2013Deutsche BankDowngradeBuyHold
Nov 13, 2013NeedhamDowngradeBuyHold
Oct 30, 2013FBR CapitalInitiated Mkt Perform
Sep 6, 2013StifelInitiated Buy
Apr 22, 2013NeedhamInitiated Buy
Apr 4, 2013Robert W. BairdInitiated Outperform
Apr 3, 2013Robert W. BairdInitiated Outperform
Nov 26, 2012Burrill Institutional ResearchInitiated Mkt Outperform

More Upgrades & Downgrades for SRPT

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy3333

Data provided by Thomson/First Call

Currency in USD.